BBCNEWS BBC News June 4, 2021 18:06:00
An independent group of scientists, thejcvi committee, will now make the decision. but it is not clear—cut. the pfizerjab is already approved and offered to those over 16 with underlying health conditions. but for the vast majority of children, the biggest harm they have faced this pandemic is not from the virus, it is from disruption to their education. they are highly unlikely to get seriously ill. there have been cases of a very nasty inflammatory condition, but those have been rare. the biggest benefit to children from immunisation would be in preventing school outbreaks. we know that th...